Bilastin-Mepha 20 mg, Tabletten
7680680020036
CH-68002
Tabletten
Associated product:
BILASTIN Mepha cpr 20 mg 50 pce
1 / 3
google
Article details
- Package size
- 50
- Selling units
- 50
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.21 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 18.40
Specialties list
Yes
Generic
Yes
SL addition date:
01/01/2023
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68002
- Drug name
- Bilastin-Mepha Tabletten
- Galenic form
- TAB
- ATC Code
- R06AX29
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 01/11/2021
- Authorization expiration date
- 31/10/2026
- IT Number
- 07.13.1.
- Domain
- Human medicine
Package details
- Description (FR)
- BILASTIN Mepha cpr 20 mg 50 pce
- Description (DE)
- BILASTIN Mepha Tabl 20 mg 50 Stk
- Market launch
- 01/11/2021
- Narcotic (BTM)
- No
Original drug
Bilaxten kids, Lösung zum Einnehmen
GTIN: 7680667120018
CHF 27.35